Title:
速放性錠剤製剤
Document Type and Number:
Japanese Patent JP2013510875
Kind Code:
A
Abstract:
The present invention provides an immediate release pharmaceutical formulation which includes a tablet or capsule formulation comprising metformin and the sodium dependent glucose transporter (SGLT2) inhibitor dapagliflozin or its propylene glycol hydrate. The present invention also provides methods of preparing the formulations and methods of treating diseases or disorders associated with SGLT2 activity employing these formulations.
Inventors:
Agneta Hallgren
Ralph Magnus Werner Svenson
Ralph Magnus Werner Svenson
Application Number:
JP2012539026A
Publication Date:
March 28, 2013
Filing Date:
November 12, 2010
Export Citation:
Assignee:
BRISTOL-MYERS SQUIBB COMPANY
AstraZeneca UK Limited
AstraZeneca UK Limited
International Classes:
A61K45/00; A61K9/14; A61K9/20; A61K9/28; A61K9/48; A61K31/137; A61K31/155; A61K31/337; A61K31/351; A61K31/403; A61K45/06; A61K47/02; A61K47/12; A61K47/32; A61K47/34; A61K47/36; A61K47/38; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/10; A61P9/12; A61P13/12; A61P17/02; A61P25/00; A61P27/02; A61P27/12; A61P43/00
Domestic Patent References:
| JP2009519934A | 2009-05-21 | |||
| JP2009537478A | 2009-10-29 | |||
| JP2013510873A | 2013-03-28 |
Foreign References:
| WO2009121945A2 | 2009-10-08 |
Other References:
C. J. BAILEY ET AL., DIABETOLOGIA, vol. 52, no. 1, JPN6014045854, October 2009 (2009-10-01), pages 76, ISSN: 0002930830
Attorney, Agent or Firm:
Kyousei Tamura
Samejima Mutsumi
Nagatoshi Shinagawa
Yasushi Morimoto
Samejima Mutsumi
Nagatoshi Shinagawa
Yasushi Morimoto